Acesion Pharma ApS

Iambic Therapeutics is the latest biopharmaceutical company to raise a venture capital mega-round in support of an artificial intelligence-powered drug discovery platform and emerging clinical-stage

Acesion Pharma ApS is on a mission to out-license its lead atrial fibrillation (AF) program for the acute setting after success in a Phase II proof-of-concept trial, a move that would enable the firm

Acesion Pharma Raises €9.1m Danish firm Acesion Pharma APS , specializing in therapies for atrial fibrillation, raised €9.1m ($10m) in the first close of what appears to be a third round to current

New At The Helm Company Changes ALEXANDER , Dana M. To: Anika Therapeutics Inc. , COO (April) From: Genzyme Corp., Senior Dir., Biologics Mfg. Ops. Phone: 781-457-9000 BECKER , Marc To: CRI